Grace Desantis

Grace DeSantis, Ph.D has a strong background in research and development within the biotechnology industry. Grace is currently working as the VP of R&D at ONI, a position they started in 2023. Prior to this, Grace took a career break in the same year. Grace also held key roles at Illumina, where they served as the Sr. Director of R&D, leading clinical product innovation in oncology and autoimmune profiling. Grace also worked as the Director of R&D, focusing on product development and building high-performance teams. Before joining Illumina, Grace worked at Sequenom as the Director of R&D, leading technical projects for non-invasive prenatal and oncology testing. Grace also spent time as the Director of R&D at Alere Inc., where they invented a blood cell stabilization technology. In the earlier years of their career, Grace held the position of Associate Director and Principal Scientist at BASF, where they focused on enzyme and protein engineering. Grace also worked as a Research Investigator at Scripps Research, where they conducted postdoctoral research and published in high-impact journals. Grace's work experience showcases their expertise in biotechnology research, product development, and innovative technical leadership.

Grace DeSantis, Ph.D has an education history that includes doctoral studies and research in the field of Biochemistry & Bio-Organic Chemistry. Grace completed their Ph.D. from the University of Toronto from 1994 to 1998. Prior to that, they attended the Scripps Research institute, although the specific details about their degree or field of study during this time are unknown.